Healthy Extracts Inc (HYEX)
2.50
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Healthy Extracts Enterprise Value: 8.425M for June 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 21, 2024 | 8.425M |
| June 20, 2024 | 8.425M |
| June 18, 2024 | 8.425M |
| June 17, 2024 | 8.425M |
| June 14, 2024 | 8.425M |
| June 13, 2024 | 8.425M |
| June 12, 2024 | 8.336M |
| June 11, 2024 | 8.336M |
| June 10, 2024 | 8.336M |
| June 07, 2024 | 8.336M |
| June 06, 2024 | 8.395M |
| June 05, 2024 | 8.395M |
| June 04, 2024 | 8.395M |
| June 03, 2024 | 8.395M |
| May 31, 2024 | 8.395M |
| May 30, 2024 | 3.714M |
| May 29, 2024 | 3.714M |
| May 28, 2024 | 3.714M |
| May 24, 2024 | 6.943M |
| May 23, 2024 | 6.943M |
| May 22, 2024 | 6.943M |
| May 21, 2024 | 6.943M |
| May 20, 2024 | 6.943M |
| May 17, 2024 | 6.943M |
| May 16, 2024 | 6.943M |
| Date | Value |
|---|---|
| May 15, 2024 | 6.943M |
| May 14, 2024 | 6.943M |
| May 13, 2024 | 6.943M |
| May 10, 2024 | 6.943M |
| May 09, 2024 | 6.943M |
| May 08, 2024 | 6.943M |
| May 07, 2024 | 6.943M |
| May 06, 2024 | 6.943M |
| May 03, 2024 | 6.943M |
| May 02, 2024 | 6.943M |
| May 01, 2024 | 6.943M |
| April 30, 2024 | 6.943M |
| April 29, 2024 | 6.943M |
| April 26, 2024 | 6.943M |
| April 25, 2024 | 6.943M |
| April 24, 2024 | 6.943M |
| April 23, 2024 | 6.943M |
| April 22, 2024 | 6.943M |
| April 19, 2024 | 6.943M |
| April 18, 2024 | 6.943M |
| April 17, 2024 | 6.943M |
| April 16, 2024 | 6.943M |
| April 15, 2024 | 6.943M |
| April 12, 2024 | 6.943M |
| April 11, 2024 | 6.943M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.472M
Minimum
Sep 27 2019
44.56M
Maximum
Sep 20 2021
16.52M
Average
17.79M
Median
Feb 09 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.982M |
| Palatin Technologies Inc | 20.48M |
| iBio Inc | 26.49M |
| Theriva Biologics Inc | -11.16M |
| Oragenics Inc | 6.100M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8613M |
| Revenue (Quarterly) | 0.6888M |
| Total Expenses (Quarterly) | 0.7509M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 59.29% |
| Profit Margin (Quarterly) | -125.0% |
| Earnings Yield | -19.03% |
| Normalized Earnings Yield | -9.102 |